528 related articles for article (PubMed ID: 11676482)
21. Cyclin E-induced S phase without activation of the pRb/E2F pathway.
Lukas J; Herzinger T; Hansen K; Moroni MC; Resnitzky D; Helin K; Reed SI; Bartek J
Genes Dev; 1997 Jun; 11(11):1479-92. PubMed ID: 9192874
[TBL] [Abstract][Full Text] [Related]
22. Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes.
Singh RP; Agarwal C; Agarwal R
Carcinogenesis; 2003 Mar; 24(3):555-63. PubMed ID: 12663518
[TBL] [Abstract][Full Text] [Related]
23. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
[TBL] [Abstract][Full Text] [Related]
24. Control of E2F activity by p21Waf1/Cip1.
Delavaine L; La Thangue NB
Oncogene; 1999 Sep; 18(39):5381-92. PubMed ID: 10498892
[TBL] [Abstract][Full Text] [Related]
25. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells.
Fan G; Ma X; Kren BT; Steer CJ
Oncogene; 1996 May; 12(9):1909-19. PubMed ID: 8649852
[TBL] [Abstract][Full Text] [Related]
26. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
Morris L; Allen KE; La Thangue NB
Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
[TBL] [Abstract][Full Text] [Related]
27. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis.
Sprenger CC; Vail ME; Evans K; Simurdak J; Plymate SR
Oncogene; 2002 Jan; 21(1):140-7. PubMed ID: 11791184
[TBL] [Abstract][Full Text] [Related]
28. Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP-1 signalling pathways.
Kim AL; Zhu Y; Zhu H; Han L; Kopelovich L; Bickers DR; Athar M
Exp Dermatol; 2006 Jul; 15(7):538-46. PubMed ID: 16761963
[TBL] [Abstract][Full Text] [Related]
29. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
Hu X; Cress WD; Zhong Q; Zuckerman KS
Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
[TBL] [Abstract][Full Text] [Related]
30. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase.
Wells J; Yan PS; Cechvala M; Huang T; Farnham PJ
Oncogene; 2003 Mar; 22(10):1445-60. PubMed ID: 12629508
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylation of E2F-1 by cyclin A-cdk2.
Kitagawa M; Higashi H; Suzuki-Takahashi I; Segawa K; Hanks SK; Taya Y; Nishimura S; Okuyama A
Oncogene; 1995 Jan; 10(2):229-36. PubMed ID: 7838523
[TBL] [Abstract][Full Text] [Related]
32. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
Kiess M; Gill RM; Hamel PA
Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
[TBL] [Abstract][Full Text] [Related]
33. Regulation of apoptosis by resveratrol through JAK/STAT and mitochondria mediated pathway in human epidermoid carcinoma A431 cells.
Madan E; Prasad S; Roy P; George J; Shukla Y
Biochem Biophys Res Commun; 2008 Dec; 377(4):1232-7. PubMed ID: 18996091
[TBL] [Abstract][Full Text] [Related]
34. Involvement of down-regulation of Cdk2 activity in hepatocyte growth factor-induced cell cycle arrest at G1 in the human hepatocellular carcinoma cell line HepG2.
Tsukada Y; Tanaka T; Miyazawa K; Kitamura N
J Biochem; 2004 Nov; 136(5):701-9. PubMed ID: 15632311
[TBL] [Abstract][Full Text] [Related]
35. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).
Vrana JA; Saunders AM; Chellappan SP; Grant S
Differentiation; 1998 May; 63(1):33-42. PubMed ID: 9615391
[TBL] [Abstract][Full Text] [Related]
36. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F.
Cao L; Faha B; Dembski M; Tsai LH; Harlow E; Dyson N
Nature; 1992 Jan; 355(6356):176-9. PubMed ID: 1530885
[TBL] [Abstract][Full Text] [Related]
37. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
Hiyama H; Iavarone A; Reeves SA
Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
[TBL] [Abstract][Full Text] [Related]
38. Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol.
Gewirtz DA; Di YM; Randolph JK; Jain PT; Valerie K; Bullock S; Nath N; Chellappan SP
Arch Biochem Biophys; 2001 Apr; 388(2):243-52. PubMed ID: 11368161
[TBL] [Abstract][Full Text] [Related]
39. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit.
Hofmann F; Livingston DM
Genes Dev; 1996 Apr; 10(7):851-61. PubMed ID: 8846921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
